[Korean Clinical Practice Guidelines for Adverse Reactions to Intravenous Iodinate and MRI-Gadolinium Contrast Agents: Revised Clinical Consensus and Recommendations (3rd Edition, 2022)].
Se Won Oh, So Young Park, Hwan Seok Yong, Young Hun Choi, Min Jae Cha, Tae Bum Kim, Ji Hyang Lee, Sae Hoon Kim, Jae Hyun Lee, Gyu Young Hur, Jae Yeon Hwang, Sejoong Kim, Hyo Sang Kim, Ji Young Ryu, Miyoung Choi, Chi-Hoon Choi
{"title":"[Korean Clinical Practice Guidelines for Adverse Reactions to Intravenous Iodinate and MRI-Gadolinium Contrast Agents: Revised Clinical Consensus and Recommendations (3rd Edition, 2022)].","authors":"Se Won Oh, So Young Park, Hwan Seok Yong, Young Hun Choi, Min Jae Cha, Tae Bum Kim, Ji Hyang Lee, Sae Hoon Kim, Jae Hyun Lee, Gyu Young Hur, Jae Yeon Hwang, Sejoong Kim, Hyo Sang Kim, Ji Young Ryu, Miyoung Choi, Chi-Hoon Choi","doi":"10.3348/jksr.2022.0024","DOIUrl":null,"url":null,"abstract":"<p><p>The Korean Society of Radiology and Medical Guidelines Committee amended the existing 2016 guidelines to publish the \"Korean Clinical Practice Guidelines for Adverse Reactions to Iodide Contrast for Injection and Gadolinium Contrast for MRI: The Revised Clinical Consensus and Recommendations (2022 Third Edition).\" Expert members recommended and approved by the Korean Society of Radiology, the Korean Academy of Asthma, Allergy and Clinical Immunology, and the Korean Nephrology Society participated together. According to the expert consensus or systematic literature review, the description of the autoinjector and connection line for the infection control while using contrast medium, the acute adverse reaction, and renal toxicity to iodized contrast medium were modified and added. We would like to introduce the revised contents.</p>","PeriodicalId":74904,"journal":{"name":"Taehan Yongsang Uihakhoe chi","volume":" ","pages":"254-264"},"PeriodicalIF":0.0000,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e8/86/jksr-83-254.PMC9514440.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Taehan Yongsang Uihakhoe chi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3348/jksr.2022.0024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/3/28 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
The Korean Society of Radiology and Medical Guidelines Committee amended the existing 2016 guidelines to publish the "Korean Clinical Practice Guidelines for Adverse Reactions to Iodide Contrast for Injection and Gadolinium Contrast for MRI: The Revised Clinical Consensus and Recommendations (2022 Third Edition)." Expert members recommended and approved by the Korean Society of Radiology, the Korean Academy of Asthma, Allergy and Clinical Immunology, and the Korean Nephrology Society participated together. According to the expert consensus or systematic literature review, the description of the autoinjector and connection line for the infection control while using contrast medium, the acute adverse reaction, and renal toxicity to iodized contrast medium were modified and added. We would like to introduce the revised contents.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
